David Palma: ctDNA as a Key Survival Predictor in Oligometastatic Lung Cancer
David Palma

David Palma: ctDNA as a Key Survival Predictor in Oligometastatic Lung Cancer

David Palma, Radiation Oncologist at London Health Sciences Centre (LHSC), Professor at Western University, shared a post on LinkedIn:

“Evidence is accumulating that ctDNA is a major prognostic (and maybe predictive) factor for oligometastatic cancers.

Check out this paper by Aadel Chaudhuri and team.”

Title: Early ctDNA stratifies survival in locally advanced and oligometastatic lung cancer treated with radiotherapy

Authors: Mario Mandalà, Monica Chen, Ryan Sullivan, Maria Chiara Sergi, Michael Postow, Aleigha Lawless, Derek Effiom, Tobias Peres, Paul Lorigan, Patricio Serra-Bellver, Reinhard Dummer, Teresa Amaral, Marie-Lena Rasch, Diana Giannarelli, Maria Grazia Vitale, Hildur Helgadottir, Caroline Robert, Martina Ubaldi, Douglas Johnson, Michele Del Vecchio, Alice Indini, Karijn Suijkerbuijk, Paul Nathan, Thomas Carter, Bart Neyns, Iris Dirven, Ines Pires da Silva, Alexander Maxwell Menzies, Lisa Zimmer, Elisabeth Livingstone, Roberta Depenni, Katharina Kähler, Axel Hauschild, Francesco Spagnolo, Anna Maria Di Giacomo, Ana Arance, Barbara Merelli, Pietro Quaglino, Ernesto Rossi, Marco Tucci, Michele Guida, Eva Muñoz-Couselo, Georgina Long, James Larkin, Paolo Ascierto

Read the article.

David Palma

Other articles featuring David Palma on OncoDaily.